Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network...
Andexanet Yields Better Control of Hematoma Expansion Than Usual Care
FRIDAY, May 17, 2024 -- For patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage, andexanet alfa, which...
Men Face More Diabetes Complications Than Women
FRIDAY, May 17, 2024 -- Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published...
U-Shaped Link Detected Between Adolescent BMI and Mental Health
FRIDAY, May 17, 2024 -- There is a U-shaped association between adolescent body mass index (BMI) and mental health, according to a study published online May...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses...
Vaping Linked to Earlier Onset of Asthma
FRIDAY, May 17, 2024 -- People with asthma who vape tend to develop the respiratory disease earlier in life than folks who never vaped, new research shows...
FDA Approves New Drug for Deadly Lung Cancer
FRIDAY, MAY 17, 2024 -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer...
U.S. Justice Department Moves to Reclassify Weed as Less Risky Drug
FRIDAY, May 17, 2024 -- The U.S. Justice Department on Thursday moved to reclassify marijuana as a less dangerous drug, setting the stage for a significant...
Global Life Expectancy Could Rise By More Than 4 Years by 2050
FRIDAY, May 17, 2024 -- Life expectancy around the world is expected to increase by nearly 5 years in men and more than 4 years in women during the next three...
Most Cancer Treatments Near End of Life Are Useless: Study
FRIDAY, May 17, 2024 -- Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows.Chemotherapies...
FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer
THOUSAND OAKS, Calif., May 16, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
PRINCETON, N.J.--(BUSINESS WIRE) May 15, 2024 -- Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted...
Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism
COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA)...
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
DEERFIELD, Ill. - 2024-05-13 -- Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded...
FDA Approves Updated Altuviiio Label With Expanded Pediatric Data Confirming Highly Effective Bleed Protection in Children With Hemophilia
Paris, May 10, 2024 -- The US Food and Drug Administration (FDA) has updated the label for Altuviiio® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN...
Select Strengths of Sandoz Biosimilar Hyrimoz Granted Interchangeability by FDA
May 08, 2024 -- On April 5, 2024, the US Food and Drug Administration (FDA) approved Sandoz’s supplemental biologics license application (sBLA) seeking...
Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
DUBLIN, Ireland and CHICAGO, April 29, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company...
Abeona Therapeutics Provides Regulatory Update on Pz-cel
CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...
Supernus Provides Regulatory Update for SPN-830
ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome
NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...
SUPERNOVA Phase III trial of Sipavibart Long-Acting Antibody Met Primary Endpoints in Preventing COVID-19 in Immunocompromised Patient Population
16 May 2024 -- Positive high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial showed AstraZeneca’s...
Elinzanetant Significantly Reduces Frequency and Severity of Moderate to Severe Hot Flashes Associated with Menopause
Berlin, May 16, 2024 – Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, showing that the investigational compound...
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug BIIB105 in Amyotrophic Lateral Sclerosis
CAMBRIDGE, Mass. and CARLSBAD, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Ionis Pharmaceuticals, Inc...
Adverse Social Determinants of Health Linked to Treatment-Resistant Hypertension in Black Americans
May 16, 2024 -- People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social...
With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin
INDIANAPOLIS, May 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-2 and QWINT-4 phase 3...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.